Orchestra BioMed Holdings Inc. (OBIO) — Long-term Investment Intensity
Orchestra BioMed Holdings Inc. (OBIO) has a Long-term Investment Intensity of 2.2% as of December 2025. Long-term investments of $2.50 Million represent 2.2% of total assets of $114.86 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Orchestra BioMed Holdings Inc. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Orchestra BioMed Holdings Inc. Long-term Investment Intensity (2020–2025)
This chart shows how Orchestra BioMed Holdings Inc.'s Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the intensity stands at 2.2%, reflecting long-term investments of $2.50 Million against total assets of $114.86 Million USD. Explore debt repayment capacity of Orchestra BioMed Holdings Inc. to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Orchestra BioMed Holdings Inc. (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for Orchestra BioMed Holdings Inc. from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see OBIO stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 2.2% | $2.50 Million | $114.86 Million | ▼ -1.1 pp |
| 2024 | 3.3% | $2.50 Million | $76.17 Million | ▲ +0.7 pp |
| 2023 | 2.6% | $2.50 Million | $95.21 Million | ▲ +0.0 pp |
| 2022 | 2.6% | $2.50 Million | $95.57 Million | ▼ -0.3 pp |
| 2021 | 2.9% | $398.00K | $13.53 Million | ▲ +2.5 pp |
| 2020 | 0.5% | $185.00K | $38.09 Million | — |